Aspen Pharmacare Holdings Limited (JSE:APN)

Aspen Pharmacare Holdings Revenue

In the fiscal year ending June 30, 2026, Aspen Pharmacare Holdings had annual revenue of 34.87B ZAR, down -1.32%. Aspen Pharmacare Holdings had revenue of 17.79B in the half year ending June 30, 2026, a decrease of -24.50%. That makes Aspen Pharmacare Holdings the 4,824th largest company in the world by revenue and 43rd in South Africa.

• Revenue: 34.87B
• Revenue Growth: -1.32%
• P/S Ratio: 2.11
• Revenue / Employee: 4.68M
• Employees: 7,625
• Market Cap: 73.48B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacturing 9.47B 27.1%
• Commercial Pharmaceuticals - Injectables 9.18B 26.3%
• Commercial Pharmaceuticals - Prescription 9.07B 26.0%
• Commercial Pharmaceuticals - OTC 7.16B 20.5%

By Geography

Chart

• Europe CIS 13.49B 38.7%
• Africa Middle East 11.71B 33.6%
• Americas 6.78B 19.4%
• China 2.78B 8.0%
• Other Asia 109.00M 0.3%

Fiscal year ended Jun 30, 2026 See the full Aspen Pharmacare Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	34.87B	-466.00M	-1.32%
Jun 30, 2025	35.34B	-9.37B	-20.96%
Jun 30, 2024	44.71B	4.00B	9.82%
Jun 30, 2023	40.71B	2.10B	5.45%
Jun 30, 2022	38.61B	840.00M	2.22%

Data Source: S&P Global Market Intelligence Last updated: Oct 2, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 8, 2026

Data Sources Report a data error